Eagle IP Recognized as Top Tier Firm (Tier 1) for Patent Prosecution in IP Stars 2024 Patent Firms Ranking List
– July 2024
Beijing IP Court Reverses CNIPA’s decision, accepting Novo Nordisk’s Post Filing Data and Ultimately Maintaining the Semaglutide “Ozempic” patent as VALID
– June 2024
A More Detailed Overview of China’s Patent Term Extension (PTE) System
– June 2024
Jennifer Che and Yolanda Wang Ranked Among Leading Patent Individuals in IAM Patent 1000 for 2024
– June 2024
Dr. Jacqueline Lui and Ms. Pauli Wong Named Patent Star 2024 by Managing IP
– June 2024
Eagle IP Ranked Among Top Tier Firms in IAM Patent 1000
– June 2024
Everything you need to know about Patent Term Adjustment (PTA) in China
– May 2024
Stay Ahead: Getting a Chinese Patent in Three Months?
– April 2024
Miss the 12-month Filing Deadline? China Finally Allows Patent Applicants to Restore, Add, or Correct a Priority Claim
– April 2024
Eagle IP is Coming Back to LSPN Spring Boston !
– March 2024
New Remedy in China for Fixing “Errors” in a Patent Application: Incorporation by Reference
– March 2024
EPO introducing Micro-entity status regime with reduced fees starting from 1 Apr 2024
– March 2024
Updates on Hong Kong Patents Examination Guidelines in 2024
– March 2024
IP Strategies for the Newly Released Implementation Regulations of the 4th Amendment of the Chinese Patent Law:Part 3: The 15-Day Mailing Period is Mostly Going Away
– February 2024
Official Fees Updates: Reduction in Hong Kong Registered Design Fees
– February 2024
IP Strategies for the Newly Released Implementation Regulations of the 4th Amendment of the Chinese Patent Law:Part 2: Grace Period without Loss of Novelty
– February 2024
IP Strategies for the Newly Released Implementation Regulations of the 4th Amendment of the Chinese Patent Law:Part 1: Delayed Examination
– January 2024
Twice the Trouble: Unraveling a Single Case of Dual Patent and Trademark Infringement
– January 2024
Appointment of Ms. Yolanda Wang as IP Advisor for HKETA
– January 2024
Do Promotional Marketing Materials Constitute an “Offer for Sale” under Chinese Patent Law? Bayer IP GmbH v. Nanjing Hang Seng Pharmaceutical
– December 2023
Top 10 China IP Board Case 2022 – Validity of RNAi InventionsDecision on Examination of Request for Invalidation (No. 58530)
– December 2023
Inventive Step for an Enantiomer over a Racemate: “L-ornidazole” Patent Invalidation Case
– November 2023
Mexico Launches Accelerated Patent Grant Initiative in Collaboration with USPTO
– November 2023
Announcement: Implementation Regulations (Rules) of the Chinese Patent Law have been Approved
– November 2023
Eagle IP Limited Honored as 2023 Patent Firm of the Year in Hong Kong
– October 2023
Jennifer Che has been listed on the IAM Strategy 300: The World’s Leading IP Strategists of the year for 2023
– October 2023
Bright Ideas, Strong Barriers: A Patenting Masterclass
– September 2023
Celebrating Jennifer Che’s Promotion to Managing Director
– August 2023
Eagle IP is Featured in IAM Patent 1000’s Top Tier of Firms
– July 2023
AIPLA’s annual Women in IP Global Networking Event
– May 2023
Eagle IP is Going to LSPN Spring Boston!
– April 2023
CNIPA further clarifies how it counts “delays” when calculating Patent Term Adjustment (PTA) in the new Draft Examination Guidelines and how it affects international applicants
– April 2023
First-Time Filer Expedited Examination Pilot Program
– April 2023
Foreigners Beware: China Proposes Requiring IP Made Using Exported Chinese Genetic Resources to be Co-Owned by Chinese Collaborators
– March 2023
No More Paper Patents at the USPTO!
– March 2023
First Ever Successful Invalidation Challenge Due to Unauthorized Foreign Filing
– March 2023
MAJOR UPDATES: New Unitary Patent System for Europe Starting 1 June 2023
– March 2023
EPO to Increase Official Fees from 1 April 2023
– February 2023
Introducing the New USPTO Cancer Moonshot Expedited Examination Pilot Program
– January 2023
Official Fees Updates: Reduced USPTO Official Fees for Small and Micro Entities and New PCT Fees
– January 2023
FOLLOW UP: Amendments to the China Patent Examination Guidelines in 2022
– January 2023
BREAKING NEWS: New Pilot Program for Hong Kong Applicants to get Accelerated Patent Examination in the Chinese Patent Office Starting January 1, 2023
– January 2023
Chinese Courts Cares More About Patent Quality Now
– December 2022
Amendments to the China Patent Examination Guidelines in 2022
– December 2022
China Proposes New Examination Guidelines for Utility Models
– November 2022
China Announcing More Proposed Amendments to the Examination Guidelines in 2022
– November 2022
US vs CN: National Security Clearance Requirements
– November 2022
Compositions Limited by Use: A Cautionary Tale
– October 2022
How the Chinese Patent Office Rejected a Plate-Making Method Based on Food Safety Law
– October 2022
China’s Supreme People’s Court (SPC) Hands Down First Patent Linkage Appeal Decision
– September 2022
Eagle IP is Recognized in IP Stars 2022 in Patent Prosecution
– September 2022
Eagle IP is Recognized in IAM Patent 1000 as a Top Tier Firm
– July 2022
SPC Upholds $2M RMB Award in China’s First Patent Case on a Biological Deposit
– July 2022
China Hands Down First Batch of Patent Linkage “Paragraph IV” Litigation Results
– June 2022
What Kind of Damage Awards Can You Get in China?
– June 2022
China Releases Draft Implementation Guidelines for the Drug Administration Law
– June 2022
Congrats to Pauli Wong Promoted to Principal
– April 2022
How Smart is a Skilled Person in the Art ?
– April 2022
Patent Eligibility for Software in China
– April 2022
Talks given by our Vice President and Principal Jennifer Che at the Patent Workshops, HKUST Entrepreneurship Center, The Hong Kong University of Science and Technology:
Patent 101: How to Read and Write a Patent: Best Practices for Scientists:
VIDEO
Patent 101 for Entrepreneurs and Start-Ups:
VIDEO
– March 2022
CHINA DIVISIONAL PATENT STRATEGY: Recent Judgment Narrows What Constitutes “Different Inventions” for Divisionals
– December 2021
CHINA: The Interplay Between Patent Law and Other Laws During Patent Prosecution
– October 2021
Proposed Examination Guidelines for the New Chinese Patent Law – Topic 1: Patent Term Adjustment
– October 2021
China Finally Clamps Down on Facial Recognition Technology
– August 2021
Do Invention and UM Patents Filed on the Same Day Rise and Fall Together?
– August 2021
What is the difference between an Invention Patent and a Utility Model Patent?
– August 2021
New Draft Patent Examination Guidelines are Available for Public Comment
– August 2021
China Top 10 Cases of 2020 – Winners’ Sun is truly a Winner: A Simple Selfie – Stick Utility Model Patent Crushes Infringers in China
– August 2021
Breaking: China Released New Implementation Measures for the New Patent Linkage System
– July 2021
China Top 10 Patent Re-Examination and Invalidation Cases of 2020 CNIPA Upholds Bayer’s Rivaroxaban Patent
– June 2021
CNIPA Releases Interim Measures for the Amended Chinese Patent Law Going Into Effect June 1, 2021
– May 2021
China Top 10 Cases of 2020 – CNIPA Upholds Second Medical Use Patent from University of Bordeaux
– May 2021
China’s Newest Examination Guidelines: Inventive Step for Biological / Life Science Inventions (Part III)
– April 2021
China’s Newest Examination Guidelines: Novelty and Inventive Step for Compounds (Part II)
– April 2021
China’s Newest Examination Guidelines: Post-Filing Supplemental Data (Part I)
– April 2021
China Adds Europe as a Searching Authority for PCT Applications
– February 2021
A Detailed Dive into China’s New Patent Term Extension Provisions
– December 2020
China Releases Details on Patent Term Extension, Deferred Examination and More in the Latest Draft Implementation Rules of the New Chinese Patent Law
– December 2020
China Releases Draft Examination Guidelines for the new Patent Law
– December 2020
How Will Civil Cases Work Under The Patent Linkage Provision In The New Chinese Patent Law?
– November 2020
New Guidelines! How to Apply China’s Criminal Law in IP Infringement
– November 2020
Narrow Claim Scope of a Chinese Utility Model Patent Fuels Design-Arounds by Failing to Curb Competing Products: Learning from a 2019 China’s Top 50 Representative IP Case
– October 2020
Breaking News: China passes Fourth Amendment to the Chinese Patent Law
– October 2020
China Forges Ahead with Draft Measures for New Patent Linkage System
– October 2020
US Patent Fees will increase effective on October 2nd
– September 2020
How Far Can an Employer Reach to Own Employee-made “Service Inventions”?
– August 2020
Polymorph Patents in China: What is the Standard for Inventiveness for New Crystal Forms?
– July 2020
China Top 50 Case of 2019: How a Functional Feature is Construed Greatly Impacts Protection Scope
– July 2020
Breaking News: Newest Draft Amendment to the Chinese Patent Law Available for Public Comment
– July 2020
How the Chinese Court Criminally Sentences Employees that Steal Trade Secrets: 2019 China’s Top 50 Representative IP Cases
– June 2020
2019 CHINA TOP 10 IP CASE: VALEO V. LUCAS, FUKE, & CHEN
– June 2020
The Latest on Post-Filing Data in China’s Patent Law
– April 2020
China Provides Specific Directions to Strengthen Patent / Technology Protection from 2020 to 2021
– April 2020
Diagnostic Claims in China
– January 2020
Hong Kong Launches New Original Grant Patent System
– December 2019
AI, Big Data, and Blockchain – CNIPA seeks public comment on draft patent examination guidelines
– November 2019
Major and Exciting Changes to China’s Patent Law on the Horizon
– February 2019
Happy Lunar New Year!
– January 2019
Finally a unified “Court of Appeal” for technology IP in China
– January 2019
Can several alternate groups in a Markush claim be arbitrarily deleted during invalidation?
– December 2018
No % homology? How to craft allowable claim scope around sequences to comply with China’s strict written description requirements
– November 2018
Can post-filing data showing unexpected technical effect be used to overcome inventive step if the specification contains no data but asserts the unexpected technical effect?
– November 2018
Is it Sufficient to Claim an Antibody only by Describing its Antigen?
– November 2018
Foreign companies transferring IP out of China: things to know
– October 2018
China IP Developments in Biotech/Pharma
– October 2018
After Final Consideration Pilot 2.0 Extended for Another Year
– October 2018
USPTO harmonizes with US courts by adopting the court’s standard for interpreting claim scope
– October 2018
Prior Art Will Be Easier to Find due to creation of a new Prior Art Archive by Google, Cisco, MIT, and USPTO
– October 2018
How do foreign parties really fare in Chinese patent litigation?
– May/June 2018
Restructuring of SIPO Explained: To Facilitate Unified Law Enforcement and Avoid Separate Administration
– April 2018
SIPO to Continue Digital Advancement
– March 2018
Patent Protection: Are Patents Enforceable in China
– February 2018
Standard-Essential Patent in China Now Have Better Protection
– July 2017
Normal Consumer is Now the Standard for Determination of Infringement on Design Patents
– July 2017
Renting Products in China Now Constitutes Design Patent Infringement
– June 2017
New Guidelines for Patent Infringement Determination
– April 2017
Amendments to the Patent Examination Guidelines in China
– March 2017
